These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31465834)

  • 21. Microfluidic droplet liquid reactors for active pharmaceutical ingredient crystallization by diffusion controlled solvent extraction.
    Tona RM; McDonald TAO; Akhavein N; Larkin JD; Lai D
    Lab Chip; 2019 Jun; 19(12):2127-2137. PubMed ID: 31114833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocrystal screening of hydroxybenzamides with benzoic acid derivatives: a comparative study of thermal and solution-based methods.
    Manin AN; Voronin AP; Drozd KV; Manin NG; Bauer-Brandl A; Perlovich GL
    Eur J Pharm Sci; 2014 Dec; 65():56-64. PubMed ID: 25218047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of PC-SAFT EOS for Pharmaceuticals: Solubility, Co-Crystal, and Thermodynamic Modeling.
    Mahmoudabadi SZ; Pazuki G
    J Pharm Sci; 2021 Jun; 110(6):2442-2451. PubMed ID: 33412168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insight of the various
    Sarathi P; Padhi S
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1523-1534. PubMed ID: 35164621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design.
    Ruether F; Sadowski G
    J Pharm Sci; 2009 Nov; 98(11):4205-15. PubMed ID: 19283772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation.
    Abramov YA; Loschen C; Klamt A
    J Pharm Sci; 2012 Oct; 101(10):3687-97. PubMed ID: 22821740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the mechanisms of formation of spherical agglomerates.
    Thati J; Rasmuson AC
    Eur J Pharm Sci; 2011 Mar; 42(4):365-79. PubMed ID: 21216285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicochemical properties, binary and ternary phase diagrams of ketoprofen.
    Hong Lu Y; Bun Ching C
    Chirality; 2004 Oct; 16(8):541-8. PubMed ID: 15290690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of pharmaceutical solubility Via NRTL-SAC and COSMO-SAC.
    Tung HH; Tabora J; Variankaval N; Bakken D; Chen CC
    J Pharm Sci; 2008 May; 97(5):1813-20. PubMed ID: 17786984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving mechanical properties of desloratadine via multicomponent crystal formation.
    Ainurofiq A; Mauludin R; Mudhakir D; Umeda D; Soewandhi SN; Putra OD; Yonemochi E
    Eur J Pharm Sci; 2018 Jan; 111():65-72. PubMed ID: 28958892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
    J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enabling the drug combination of celecoxib through a spherical co-agglomeration strategy with controllable and stable drug content and good powder properties.
    Guo S; Yu C; Feng S; Wei J; Tong L; Li K; Gao Y; Zhao P; Li T; Chen M; Han D; Gong J
    Int J Pharm; 2022 Oct; 626():122180. PubMed ID: 36087627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of niflumic acid prepared by rapid microwave-assisted evaporation.
    Radacsi N; Stefanidis GD; Szabó-Révész P; Ambrus R
    J Pharm Biomed Anal; 2014 Sep; 98():16-21. PubMed ID: 24873734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery and investigation of a crystalline solid solution of an active pharmaceutical ingredient.
    Patel MA; AbouGhaly MHH; Chadwick K
    Int J Pharm; 2017 Oct; 532(1):166-176. PubMed ID: 28847668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermodynamics of solutions I: benzoic acid and acetylsalicylic acid as models for drug substances and the prediction of solubility.
    Perlovichl GL; Bauer-Brandl A
    Pharm Res; 2003 Mar; 20(3):471-8. PubMed ID: 12669971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solubility of molecular crystals: polymorphism in the light of solubility theory.
    Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
    Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agglomerative crystallization of ABT-510 in a partially miscible solvent system.
    Sheikh AY; Pal A; Viswanath S; Tolle JC
    J Pharm Sci; 2008 Mar; 97(3):1202-12. PubMed ID: 17683060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermochemical investigations of nearly ideal binary solvents. VII: Monomer and dimer models for solubility of benzoic acid in simple binary and ternary solvents.
    Acree WE; Bertrand GL
    J Pharm Sci; 1981 Sep; 70(9):1033-6. PubMed ID: 6101149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.